Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer

BACKGROUND: Dysregulated histone methyltransferase G9a may represent a potential cancer therapeutic target. The roles of G9a in tumorigenesis and therapeutics are not well understood in non-small cell lung cancer (NSCLC). Here we investigated the impact of G9a on tumor growth and signaling pathways...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Keqiang, Wang, Jinhui, Yang, Lu, Yuan, Yate-Ching, Tong, Tommy R., Wu, Jun, Yun, Xinwei, Bonner, Melissa, Pangeni, Rajendra, Liu, Zheng, Yuchi, Tiger, Kim, Jae Y., Raz, Dan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198520/
https://www.ncbi.nlm.nih.gov/pubmed/30348169
http://dx.doi.org/10.1186/s12943-018-0896-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198520/
https://www.ncbi.nlm.nih.gov/pubmed/30348169
http://dx.doi.org/10.1186/s12943-018-0896-8

Ejemplares similares